CH 339 K Proteins Amino Acids Primary Structure

  • Slides: 55
Download presentation
CH 339 K Proteins: Amino Acids, Primary Structure, and Molecular Evolution

CH 339 K Proteins: Amino Acids, Primary Structure, and Molecular Evolution

a-Amino Acid a

a-Amino Acid a

 • All amino acids as incorporated are in the L-form • Some amino

• All amino acids as incorporated are in the L-form • Some amino acids can be changed to D- after incorporation • D-amino acids occur in some non-protein molecules

I prefer this layout, personally…

I prefer this layout, personally…

2 Amides

2 Amides

The Acidic and the Amide Amino Acids Exist as Conjugate Pairs

The Acidic and the Amide Amino Acids Exist as Conjugate Pairs

Ionizable Side Chains

Ionizable Side Chains

Hydrogen Bond Donors / Acceptors

Hydrogen Bond Donors / Acceptors

Disulfide formation

Disulfide formation

Modified Amino Acids 4 -Hydroxyproline Collagen 5 -Hydroxylysine Collagen 6 -N-Methyllysine Histones g-Carboxygultamate Clotting

Modified Amino Acids 4 -Hydroxyproline Collagen 5 -Hydroxylysine Collagen 6 -N-Methyllysine Histones g-Carboxygultamate Clotting factors Desmosine Elastin Selenocysteine Several enzymes (e. g. glutathione peroxidase)

A Modified Amino Acid That Can Kill You Histidine Diphthamide (2 -Amino-3 -[2 -(3

A Modified Amino Acid That Can Kill You Histidine Diphthamide (2 -Amino-3 -[2 -(3 -carbamoyl-3 -trimethylammoniopropyl)-3 H-imidazol-4 -yl]propanoate)

Diphthamide Continued – Elongation Factor 2 • Diphthamide is a modified Histidine residue in

Diphthamide Continued – Elongation Factor 2 • Diphthamide is a modified Histidine residue in Eukaryotic Elongation Factor 2 • EF-2 is required for the translocation step in protein synthesis

Corynebacterium diphtheriae Corynebacteriophage

Corynebacterium diphtheriae Corynebacteriophage

Diphtheria Toxin Action • Virus infects bacterium • Infected bacxterium produces toxin • Toxin

Diphtheria Toxin Action • Virus infects bacterium • Infected bacxterium produces toxin • Toxin binds receptor on cell • Receptor-toxin complex is endocytosed • Endocytic vessel becomes acidic • Receptor releases toxin • Toxin escapes endocytic vessel into cytoplasm • Bad things happen

Diphtheria Toxin Action • Diphtheria toxin adds a bulky group to diphthamide • e.

Diphtheria Toxin Action • Diphtheria toxin adds a bulky group to diphthamide • e. EF 2 is inactivated • Cell quits making protein • Cell(s) die • Victim dies

Other Amino Acids

Other Amino Acids

Every a-amino acid has at least 2 p. Ka’s

Every a-amino acid has at least 2 p. Ka’s

Polymerization DG 0’ = +10 -15 k. J/mol

Polymerization DG 0’ = +10 -15 k. J/mol

In vivo, amino acids are activated by coupling to t. RNA Polymerization of activated

In vivo, amino acids are activated by coupling to t. RNA Polymerization of activated a. a. : DGo’ = -15 -20 k. J/mol

 • In vitro, a starting amino acid can be coupled to a solid

• In vitro, a starting amino acid can be coupled to a solid matrix • Another amino acid with • A protected amino group • An activating group at the carboxy group • Can be coupled • This method runs backwards from in vivo synthesis (C N)

Peptide Bond

Peptide Bond

Resonance stabilization of peptide bond

Resonance stabilization of peptide bond

Cis-trans isomerization in prolines • Other amino acids have a trans-cis ratio of ~

Cis-trans isomerization in prolines • Other amino acids have a trans-cis ratio of ~ 1000: 1 • Prolines have cis: trans ratio of ~ 3: 1 • Ring structure of proline minimizes DG 0 difference

MOLECULAR EVOLUTION

MOLECULAR EVOLUTION

Neutral Theory of Molecular Evolution • Kimura (1968) • Mutations can be: – Advantageous

Neutral Theory of Molecular Evolution • Kimura (1968) • Mutations can be: – Advantageous – Detrimental – Neutral (no good or bad phenotypic effect) • Advantageous mutations are rapidly fixed, but really rare • Diadvantageous mutations are rapidly eliminated • Neutral mutations accumulate

What Happens to a Neutral Mutation? • Frequency subject to random chance • Will

What Happens to a Neutral Mutation? • Frequency subject to random chance • Will carrier of gene reproduce? • Many born but few survive – Partly selection – Mostly dumb luck • Gene can have two fates – Elimination (frequent – Fixation (rare)

Genetic Drift in Action Our green genes are evolutionarily superior! Ow! Never mind…

Genetic Drift in Action Our green genes are evolutionarily superior! Ow! Never mind…

Simulation of Genetic Drift • 100 Mutations x 100 generations: • 1 gets fixed

Simulation of Genetic Drift • 100 Mutations x 100 generations: • 1 gets fixed • 2 still exist • 97 eliminated (most almost immediately) 1 Frequency 0. 8 0. 6 0. 4 0. 2 0 0 25 50 Generation 75 100

Rates of Change

Rates of Change

Protein Evolution Rates Different proteins have different rates

Protein Evolution Rates Different proteins have different rates

Protein Evolution Rates Different proteins have different rates

Protein Evolution Rates Different proteins have different rates

Rates (cont. ) • Slow rates in proteins critical to basic functions • E.

Rates (cont. ) • Slow rates in proteins critical to basic functions • E. g. histones ≈ 6 x 10 -12 changes/a. a. /year

Rates (cont. ) Fibrinopeptides • Theoretical max mutation rate • Last step in blood

Rates (cont. ) Fibrinopeptides • Theoretical max mutation rate • Last step in blood clotting pathway • Thrombin converts fibrinogen to fibrin

Fibrinopeptides keep fibrinogens from sticking together.

Fibrinopeptides keep fibrinogens from sticking together.

Rates (cont. ) • Only constraint on sequence is that it has to physically

Rates (cont. ) • Only constraint on sequence is that it has to physically be there • Fibrinopeptide limit ≈ 9 x 10 -9 changes/a. a. /year

Amino acid sequences of several ribosome-inhibiting proteins

Amino acid sequences of several ribosome-inhibiting proteins

Phylogenetic trees built from the amino acid sequences of type 1 RIP or A

Phylogenetic trees built from the amino acid sequences of type 1 RIP or A chains (A) and B chains (B) of type 2 RIP (ricin-A, ricin-B, and lectin RCAA and RCA-B from castor bean; abrin -A, abrina/b-B, and agglutinin APA-A and APA-B from A. precatorius; SNAI -A and SNAI-B, SNAV-A and SNAV-B, SNAI'-A and SNAI'-B, LRPSN 1 -A and LRPSN 1 -B, LRPSN 2 -A and LRPSN 2 B, and SNA-IV from S. nigra; sieboldinb-A, sieboldinb-B, SSAI-A, and SSAI-B from S. sieboldiana; momordin and momorcharin from Momordica charantia; MIRJA from Mirabilis jalapa; PMRIPm-A and PMRIPm-B, PMRIPt-A and PMRIPt-B from Polygonatum multiflorum; RIPIri. Hol. A 1, RIPIri. Hol. A 2, and RIPIri. Hol. A 3 from iris hybrid; IRAr-A and IRAr-B, IRAb-A and IRAb-B from iris hybrid; SAPOF from S. officinalis; luffin-A and luffin-B from Luffa cylindrica; and karasurin and trichosanthin from Trichosanthes kirilowii) Hao Q. et. al. Plant Physiol. 2010: 125: 866 -876

Phylogenetic tree of Opisthokonts, based on nuclear protein sequences Iñaki Ruiz-Trillo, Andrew J. Roger,

Phylogenetic tree of Opisthokonts, based on nuclear protein sequences Iñaki Ruiz-Trillo, Andrew J. Roger, Gertraud Burger, Michael W. Gray & B. Franz Lang (2008) Molecular Biology and Evolution, Jan 9